These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9135993)

  • 1. Comparative genomic hybridization reveals previously undescribed amplifications and deletions in the chronic myeloid leukemia-derived K-562 cell line.
    Rodley P; McDonald M; Price B; Fright R; Morris C
    Genes Chromosomes Cancer; 1997 May; 19(1):36-42. PubMed ID: 9135993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic imbalances in CML blast crisis: 8q24.12-q24.13 segment identified as a common region of over-representation.
    Gribble SM; Reid AG; Roberts I; Grace C; Green AR; Nacheva EP
    Genes Chromosomes Cancer; 2003 Aug; 37(4):346-58. PubMed ID: 12800146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization.
    Gribble SM; Roberts I; Grace C; Andrews KM; Green AR; Nacheva EP
    Cancer Genet Cytogenet; 2000 Apr; 118(1):1-8. PubMed ID: 10731582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of G-banding, chromosome painting, locus-specific fluorescence in situ hybridization, and comparative genomic hybridization in chronic myeloid leukemia blast crisis.
    Gribble SM; Sinclair PB; Grace C; Green AR; Nacheva EP
    Cancer Genet Cytogenet; 1999 May; 111(1):7-17. PubMed ID: 10326584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions adjacent to BCR and ABL1 breakpoints occur in a substantial minority of chronic myeloid leukemia patients with masked Philadelphia rearrangements.
    De Melo VA; Milojkovic D; Marin D; Apperley JF; Nacheva EP; Reid AG
    Cancer Genet Cytogenet; 2008 Apr; 182(2):111-5. PubMed ID: 18406872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
    Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
    Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duplication of chromosome 9 carrying a BCR/ABL chimeric gene in Philadelphia chromosome negative chronic myeloid leukemia.
    Takahashi N; Miura I; Ohshima A; Utsumi S; Nimura T; Hashimoto K; Saito M; Miura AB
    Cancer Genet Cytogenet; 1996 Jul; 89(2):166-9. PubMed ID: 8697426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
    Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
    Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of bcr/abl fusion gene and its derivative chromosome 9 deletions in CML by using home-made bcr/abl extra-signal probe].
    Lai YY; Feng L; Wang Z; Lü S; Dang H; Shi Y; He Q; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):199-203. PubMed ID: 20137147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression.
    Brazma D; Grace C; Howard J; Melo JV; Holyoke T; Apperley JF; Nacheva EP
    Genes Chromosomes Cancer; 2007 Nov; 46(11):1039-50. PubMed ID: 17696194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature.
    Ichinohasama R; Miura I; Takahashi N; Sugawara T; Tamate E; Endoh K; Endoh F; Naganuma H; DeCoteau JF; Griffin JD; Kadin ME; Ooya K
    Leukemia; 2000 Jan; 14(1):169-82. PubMed ID: 10637493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-199b associated with imatinib drug resistance in 9q34.1 deleted BCR/ABL positive CML patients.
    Joshi D; Chandrakala S; Korgaonkar S; Ghosh K; Vundinti BR
    Gene; 2014 Jun; 542(2):109-12. PubMed ID: 24680705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.
    Morel F; Bris MJ; Herry A; Calvez GL; Marion V; Abgrall JF; Berthou C; Braekeleer MD
    Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCR/ABL fusion located on chromosome 9 in chronic myeloid leukemia with a masked Ph chromosome.
    Mohamed AN; Koppitch F; Varterasian M; Karanes C; Yao KL; Sarkar FH
    Genes Chromosomes Cancer; 1995 Jun; 13(2):133-7. PubMed ID: 7542908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia.
    Gargallo PM; Cuello MT; Aranguren PN; Larripa IB
    Cancer Genet Cytogenet; 2003 Jun; 143(2):140-4. PubMed ID: 12781448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.